HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Proline prodrug of melphalan, prophalan-L, demonstrates high therapeutic index in a murine melanoma model.

Abstract
The therapeutic efficacy of prophalan-L, the L-proline prodrug of melphalan that demonstrated prolidase-dependent bioactivation to melphalan, was examined in vivo in a mouse melanoma model. Prophalan-L exhibited 2- to 2.5-fold higher hydrolytic and cytotoxic activity than prophalan-D, the D-analog, in B16-F10 murine melanoma cells in vitro. Prophalan-L cytotoxicity in B16-F10 cells was lower (GI50=221 microM) than that of melphalan (GI50=173 microM). The tumor growth profiles in C57BL/6J mice injected with B16-F10 cells and treated with melphalan (5.5 microg/g i.p.) and equimolar concentrations of the prodrugs demonstrated significant difference between the control (buffered saline) and melphalan or prophalan-L but no significant difference between control and prophalan-D or between melphalan and prophalan-L. Prophalan-L was significantly less toxic than melphalan, while no significant difference was observed in toxicity, measured as percent weight loss, between the prodrugs and saline control. Tumor reduction efficacy at high doses (12 microg/g i.p.) was similar for melphalan and prophalan-L; however, fatal toxicity was associated with melphalan while prophalan-L exhibited significantly lower systemic toxicity. An excellent correlation between GI50 and tumor reduction efficacy was observed for the tested drugs (r2=0.95). Prophalan-L thus demonstrates higher therapeutic index than melphalan in the murine melanoma model.
AuthorsSachin Mittal, Yasuhiro Tsume, Christopher P Landowski, Kyung-Dall Lee, John M Hilfinger, Gordon L Amidon
JournalEuropean journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V (Eur J Pharm Biopharm) Vol. 67 Issue 3 Pg. 752-8 (Nov 2007) ISSN: 0939-6411 [Print] Netherlands
PMID17560100 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • Antineoplastic Agents, Alkylating
  • Indicators and Reagents
  • Prodrugs
  • prophalan
  • Proline
  • Melphalan
Topics
  • Animals
  • Antineoplastic Agents, Alkylating (metabolism, therapeutic use)
  • Body Weight (drug effects)
  • Calorimetry
  • Cell Proliferation (drug effects)
  • Chromatography, High Pressure Liquid
  • Female
  • Hydrolysis
  • Indicators and Reagents
  • Melanoma, Experimental (drug therapy, pathology)
  • Melphalan (analogs & derivatives, metabolism, therapeutic use)
  • Mice
  • Mice, Inbred C57BL
  • Prodrugs (metabolism, therapeutic use)
  • Proline (analogs & derivatives, metabolism, therapeutic use)
  • Spectrophotometry, Ultraviolet
  • Stereoisomerism
  • Survival Analysis

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: